Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > What year did GUD start trading?

<< Previous

Bullboard Posts

Next >>

Comment by drippingsnoton Aug 28, 2020 12:18pm

56 Views

Post# 31470072

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:What year did GUD start trading?

I'm not twisting anything.
Fact is, a small number of people control a majority of shares.
They in turn control the company and they are giving Goodman the the go-ahead.
That's the fact.

Seriously, if you can't see that, it's too bad for you.

I will continue to remind you of this fact you anyone says Goodman has to do anything that he doesn't want to do. Not in the cards right now. That's a fact.

Maybe at the next AGM you can vote those shares you never vote - hahaha !

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects